Master Investor 2022: Our CEO, Dr. Greg Bailey, presents Juvenescence
The investment community is chasing a longer, healthier life like the rest of us.
The Simple Biotech Podcast: ‘Investing in the Longevity Industry: The Greatest Investment Opportunity in Human History’
What makes longevity one of the greatest investment opportunities in human history?
Juvenescence Chairman explains why investing in longevity has the potential to deliver significant financial, personal and humanitarian returns.
There’s a lot of great stuff happening, but it’s not one drug that’s going to keep you alive another 10 years in good health
THE BUCK INSTITUTE, WHERE THE PROMISE OF AGING RESEARCH ISN’T LONGEVITY
The leaders of the Buck Institute for Research on Aging want you to know that they’re not going to make you immortal.
Longevity Technology: Equity investment in MDI Therapeutics by Juvenescence will develop novel serpin-based therapies
Longevity Technology reports on Juvenescence investment in the important work of MDI Therapeutics.
M2Bio Sciences Interview: Dr. Greg Bailey Goes Deep on Juvenescence, Longevity Biotech, and His Personal Story
Greg goes deep on Juvenescence, longevity biotech and his personal story.